← Eichor
Study identifier: NCT06830590 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population

Condition: Breast Cancer · Molecular Pathway Deregulation · Treatment  ·  Sponsor: Liaquat University of Medical & Health Sciences

PhaseN/A
Planned participants300
Who can joinFemale, N/A to no upper limit
Healthy volunteersNo

About this study

This study is looking at the biological characteristics of early operable primary breast cancer in Pakistani Population by using IHC

This description comes directly from the study's public registry record.

Talk to the study team

Binafsha Manzoor M Syed, MBBS, PhD  ·  +923332749201  ·  Binafsha.syed@lumhs.edu.pk

Always discuss trial participation with your own doctor first.

Locations (1)

Binafsha M SyedJamshoro, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06830590